Oklo (OKLO) CFO executes options and reports multi-trade sales Sept 2025
Rhea-AI Filing Summary
Oklo Inc. CFO Richard Craig Bealmear reported multiple transactions in Class A common stock on September 17-18, 2025. He exercised two tranches of stock options at an exercise price of $3.18 each, acquiring 100,000 shares on 09/17/2025 and another 100,000 shares on 09/17/2025 (derivative filings show 100,000 options vesting and underlying 100,000 shares each). Following these exercises and subsequent open-market sales, reported holdings of Class A common stock changed across the filings: balances reported include 175,738, 129,535, and 121,913 shares at different points. Sales disclosed include 46,175, 46,203, and 7,622 shares sold at weighted average prices noted between $93.00 and $101.44. The filer certified the Form 4 on 09/19/2025 and provided a footnote that one sale price is a weighted average of multiple executions between $93.00 and $93.11.
Positive
- Option exercise disclosure at a low strike of $3.18 shows realization of long-term compensation aligned with documented vesting.
- Detailed sales pricing provided including a weighted-average range ($93.00–$93.11) and an offer to supply per-trade pricing on request, increasing transparency.
Negative
- Significant open-market sales totaling ~100,000+ shares sold across reported transactions, which materially reduced the reporting person's holdings.
- Multiple post-exercise sales at high market prices ($93–$101.44) could increase available float from insider dispositions, though the filing does not state company context.
Insights
TL;DR: Insider exercised options at a low strike and sold significant shares at market prices above $93, altering direct holdings materially.
The reporting shows option exercises at a $3.18 strike followed by substantial open-market sales executed at prices ranging from $93.00 to $101.44. These transactions increased the reporting person’s direct share count via exercises and then reduced holdings through multiple sales, with post-transaction beneficial ownership figures reported at 175,738, 129,535, and 121,913 shares. For investors, this confirms standard option-to-sale activity by an officer; the sizes of sales relative to reported holdings are material to monitoring insider supply but the filing does not include company-wide context such as total shares outstanding.
TL;DR: Officer disclosed option vesting and multiple sales; documentation includes required explanatory footnotes and signature.
The Form 4 includes necessary disclosures: exercise details including vesting schedule disclosure, weighted-average sale price footnote, and a manual signature dated 09/19/2025. The filing notes the option vested partially earlier (20% vested August 1, 2024) and continues vesting monthly. This filing appears compliant with Section 16 reporting requirements and supplies the issuer or SEC staff with offer to provide transaction-by-transaction pricing breakdowns upon request.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 7,622 | $101.4409 | $773K |
| Exercise | Stock Options | 100,000 | $0.00 | -- |
| Exercise | Stock Options | 100,000 | $0.00 | -- |
| Exercise | Class A Common Stock | 100,000 | $3.18 | $318K |
| Sale | Class A Common Stock | 46,175 | $94.45 | $4.36M |
| Exercise | Class A Common Stock | 100,000 | $3.18 | $318K |
| Sale | Class A Common Stock | 46,203 | $93.0021 | $4.30M |
Footnotes (1)
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.00 to $93.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4. The stock option vested as to 20% of the underlying shares on August 1, 2024 and continues to vest thereafter in 48 substantially equal monthly installments.
FAQ
What insider transactions did Oklo (OKLO) report on Form 4?
What was the exercise price and vesting detail for the options exercised?
When was the Form 4 signed by the reporting person?